Literature DB >> 11874885

Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies.

Mariko Yoshida1, Sadayoshi Torigoe, Masao Yamada.   

Abstract

Human herpesvirus 6 (HHV-6) is closely related to HHV-7 in terms of genome organization and sequence. The cross-reactive responses between HHV-6 and HHV-7 have been reported by using immunofluorescent techniques. Recently we have shown that neutralizing (NT) antibody responses are specific to each virus and do not cross-react. We took advantage of this and used the NT antibody response to estimate the time of seroconversion to each virus and examined the pattern of humoral immune response, especially the immunoglobulin M (IgM) response, against each virus antigen in the natural course of infection with HHV-6 and HHV-7. In children who experienced HHV-6 infection first, followed by HHV-7 infection, the IgM response at the first HHV-6 infection was directed only against HHV-6, while no IgM response was directed against HHV-7 at the second HHV-7 infection. In contrast, in children who experienced HHV-7 infection first, followed by HHV-6 infection, the IgM response at the first HHV-7 infection was directed not only against HHV-7 but also against HHV-6. These data suggest that cross-reactive responses to heterologous viruses should be taken into consideration when making a diagnosis based on IgM antibody.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874885      PMCID: PMC119945          DOI: 10.1128/cdli.9.2.394-402.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Comparison of antiviral compounds against human herpesvirus 6 and 7.

Authors:  M Yoshida; M Yamada; T Tsukazaki; S Chatterjee; F D Lakeman; S Nii; R J Whitley
Journal:  Antiviral Res       Date:  1998-12       Impact factor: 5.970

2.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

3.  Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.

Authors:  V Descamps; A Valance; C Edlinger; A M Fillet; M Grossin; B Lebrun-Vignes; S Belaich; B Crickx
Journal:  Arch Dermatol       Date:  2001-03

Review 4.  Human herpesviruses 6 and 7: effects on hematopoiesis and mode of transmission.

Authors:  M Yamada
Journal:  Jpn J Infect Dis       Date:  2001-04       Impact factor: 1.362

5.  Isolation of a new herpesvirus from human CD4+ T cells.

Authors:  N Frenkel; E C Schirmer; L S Wyatt; G Katsafanas; E Roffman; R M Danovich; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Kumiko Ikeue; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro.

Authors:  G R Pietroboni; G B Harnett; M R Bucens
Journal:  J Virol Methods       Date:  1989 Apr-May       Impact factor: 2.014

8.  Human herpesvirus 7: another causal agent for roseola (exanthem subitum).

Authors:  K Tanaka; T Kondo; S Torigoe; S Okada; T Mukai; K Yamanishi
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  2 in total

1.  Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Kumiko Ikeue; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.